Skip to main content

Positive study results for Pain Therapeutics

Pain Therapeutics Inc. (Nasdaq: PTIE) reported positive results from a human abuse potential study of its late stage drug candidate REMOXY. Shares of the biopharmaceutical more than doubled by leaping $4.82 to closes at $9.04.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.